In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to ...

AstraZeneca and Future Biogas today announced that the UK’s first unsubsidized biomethane plant dedicated to fuelling the ...

The Cambridge, England-based pharmaceuticals firm said Enhertu, or trastuzumab deruxtecan, has been approved in the EU as a therapy for adult patients with unresectable or metastatic hormone ...

the United States’ Array BioPharma and Targacept Ltd and Danish 7TM Pharma. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company ...

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company, and ...

AstraZeneca ditches UK investment over cut in state support The transaction is expected to close in the second quarter of 2025, and does not impact AstraZeneca’s financial guidance for 2025 ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

A further 180 fishermen will be vaccinated this weekend (Pic Fortuna Ltd) The Falkland Islands Government has received a batch of Oxford/AstraZeneca Covid-19 vaccines, supplied by the UK government.

Mr. Kiyoshi Kaneko appointed as Chief Commercial Officer, and Ms. Mariko Nakafuji promoted to Chief Legal Officer Tokyo, ...

The upcoming Therapeutic Oligonucleotides 2025 conference, hosted by ELRIG, will take place at AstraZeneca’s R&D site in ...

By Chandini Monnappa (Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, seeking to accelerate the development of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...